Health in Australia

  • Australians are increasingly returning from overseas with multi-drug-resistant superbugs,

    AUSTRALIA, 2014/02/03 Australians are increasingly returning from overseas with multi-drug-resistant superbugs, prompting warnings for hospitals to isolate high-risk patients to stop their spread. Infectious diseases expert Lindsay Grayson said, until recently, superbug infections in Australia were confined to patients with weakened immune systems who had taken lots of antibiotics. But he said hospitals were facing patients infected with superbugs next overseas travel, and a lot of of them were hospitalised during their trip next becoming ill.

  • Australia's Ramsay teams up with Sime

    INDONESIA, 2013/03/28 Ramsay Health Care Ltd, Australia’s biggest operator of private hospitals, agreed to start an equal joint venture with Sime Darby Bhd to manage their Asian health-care assets. Ramsay’s three hospitals in Indonesia will be combined with Sime Darby’s Malaysian assets, the Sydney-based company said in a statement to the Australian stock exchange today.

  • Australian expansion into the African market

    AUSTRALIA, 2013/03/17 Australian-based pharmaceutical and medical technologies business, LINK Healthcare today announced its expansion into the African market via South Africa’s Equity Pharma Group.

  • Australia Pharmaceuticals & Healthcare Analyse january 2011

    AUSTRALIA, 2011/01/20 The outlook for Australia's pharmaceutical market is challenging. Combined sales of prescription drugs and over-the-counter (OTC) medicines in Australia are estimate to decrease from AUD10.02bn (US$7.95bn) in 2009 to AUD9.30bn (US$7.48bn) in 2014, primarily as a result of the patent cliff. Since the last update of BMI's Pharmaceuticals & Healthcare Statement, we have significantly downgraded our estimate for pharmaceutical sales in Australia.
Trending Articles